<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00525928</url>
  </required_header>
  <id_info>
    <org_study_id>0707-003</org_study_id>
    <nct_id>NCT00525928</nct_id>
  </id_info>
  <brief_title>Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients</brief_title>
  <official_title>Assessment of Response to Open-label Treatment With Varenicline in Psychiatric Inpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Butler Hospital</source>
  <brief_summary>
    <textblock>
      This study of psychiatric inpatients will assess mood effects of varenicline, as well as&#xD;
      assess if varenicline decreased nicotine cravings acutely.&#xD;
&#xD;
      This study will also measure side effects of varenicline when given in addition to other&#xD;
      psychiatric and non-psychiatric medications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will measure mood effects and rapid anti-craving effects of varenicline in&#xD;
      psychiatric inpatients. Patients will be offered to participate in the trial if they wish to&#xD;
      stop smoking or wish to decrease nicotine cravings while in the hospital. They will not be&#xD;
      able to use nicotine replacement products when taking varenicline.&#xD;
&#xD;
      Patients will be assessed with the QIDS-SR16, Minnesota Nicotine Withdrawal Scale as well as&#xD;
      the Frequency, Intensity, and Burden of Side Effects (FISER) at baseline and daily during the&#xD;
      trial; patients will be asked to enroll for the duration of their hospitalization. Patients&#xD;
      will be assessed as to whether they wish to continue varenicline post-discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    insufficient recuirment&#xD;
  </why_stopped>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement in Quick Inventory of Depressive Symptoms (QIDS-SR)</measure>
    <time_frame>duration of hospitalization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>improvement in Minnesota Nicotine Withdrawal Scale</measure>
    <time_frame>days (duration of hospitalization)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>no significant intolerability, measured by the Frequency, Intensity, and Burden of Side Effects (FIBSER) and Adverse Events Checklist (SAFTEE-SI)</measure>
    <time_frame>duration of hospitalization</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Smoking</condition>
  <condition>Depressive Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>varenicline</intervention_name>
    <description>varenicline 0.5mg daily for days 1-3, 0.5mg twice daily for days 3-7, then 1mg twice daily for length of hospitalization</description>
    <other_name>Chantix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Admission to Butler Hospital during study period.&#xD;
&#xD;
          2. Current tobacco users ages 18-65.&#xD;
&#xD;
          3. Able to give written, informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Past adverse reaction to varenicline.&#xD;
&#xD;
          2. Treatment with varenicline on admission to Butler Hospital.&#xD;
&#xD;
          3. Renal failure or dialysis&#xD;
&#xD;
        (3) Current pregnancy or breastfeeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noah S Philip, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence H Price, MD</last_name>
    <role>Study Director</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>September 4, 2007</study_first_submitted>
  <study_first_submitted_qc>September 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2007</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <keyword>craving</keyword>
  <keyword>smoking</keyword>
  <keyword>depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varenicline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

